Stem Cell Transplantation Shows Potential for Reducing Disability in Patients with Multiple Sclerosis

January 21, 2015

(Medical Xpress) – Results from a preliminary study indicate that among patients with relapsing-remitting multiple sclerosis (MS), treatment with nonmyeloablative hematopoietic stem cell transplantation (low intensity stem cell transplantation) was associated with improvement in measures of disability and quality of life, according to a study in the January 20 issue of JAMA.